Navigation Links
Joint Replacement Patients with Diabetes Greatly Benefit from Controlled Glucose
Date:7/1/2009

New study finds controlled glucose levels help decrease chance for complications

ROSEMONT, Ill., July 1 /PRNewswire-USNewswire/ -- Diabetics undergoing total joint replacement often are at a higher risk of experiencing complications after surgery due to various pre-existing health conditions. According to a new study published in the July 2009 issue of The Journal of Bone and Joint Surgery (JBJS), those complications are less likely to occur when a diabetic patient has glucose levels under control.

"We found that controlled glucose levels really do make a difference for the patient," said study co-author Milford Marchant Jr., MD, an orthopaedic surgeon who conducted the study with colleagues of the Adult Reconstruction Section at Duke University Medical Center.

The study found that patients with uncontrolled glucose levels were:

  • More than 3 times as likely to experience a stroke or death after joint replacement surgery; and
  • About twice as likely to experience post-operative bleeding and infection.

Dr. Marchant and his colleagues reviewed data from a national healthcare database looking at more than one million patients who had total joint replacement surgery from 1988 to 2005. They compared surgical outcomes in patients with uncontrolled glucose levels to those who had controlled glucose levels and those patients who did not have diabetes.

"It did not matter if the patient had Type I or Type II diabetes," explains Dr. Marchant. "Regardless of diabetes type, we found that patients had fewer complications after surgery if their glucose level was controlled before, during and after surgery."

Diabetic patients with uncontrolled glucose were more likely to experience surgical complications, infection, blood transfusions and longer hospitals stays.

"The factors necessary for diabetic patients to be considered 'under control' are different for each individual patient, therefore diabetic patients should have good relationships with their medical doctors," said Dr. Marchant.

Study authors say that according to the American Diabetes Association, disease control is determined for each patient based on a series of laboratory blood tests and an assessment of diabetes-related illnesses. Approximately 8 percent of patients undergoing total hip and knee replacement in the United States have diabetes.

"It is crucial that patients have glucose levels well managed before, during and after surgery because it reduces the potential of having a complication," notes Dr. Marchant. "This is the responsibility of both the patient and the surgeon, and it should be a priority."

Disclosure: The authors did not receive any outside funding or grants in support of their research for or preparation of this work. Neither they nor a member of their immediate families received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. Commercial entities (Zimmer and DePuy) paid or directed in any one year, or agreed to pay or direct, benefits in excess of $10,000 to a research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which one or more of the authors, or a member of his or her immediate family, is affiliated or associated.


'/>"/>
SOURCE American Academy of Orthopaedic Surgeons
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America
2. NTU and Sembcorp to jointly explore novel waste water treatment technology
3. Pointer Announces Negotiations by Shagrir for Formation of a Joint Venture With a Third Party for the Provision of Services to Insurance Companies in the Field of Dental Care
4. Women's Health Expert Dr. Susan Lark Featured on Searchjointpain.com
5. Platelet Rich Plasma Therapy (PRP) Accelerates Healing of Joint Injuries, Osteoarthritis Pain
6. Joint Commission President Emeritus Joins Truman Medical Centers Board of Directors
7. BurrellesLuce Executive to Speak on Measuring Communications Impact At Joint Seminar of Port-Industry Group and PRSA's Detroit Chapter
8. Joint Statement on Atypical Antipsychotic Use in Children
9. ASH and EHA Jointly Announce Translational Research Training in Hematology Program
10. ASH and EHA jointly announce translational research training in hematology program
11. Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... Contrary to popular perception, ... is declining—and at noteworthy rates. Between 2002 and 2014, Salas-Wright and his colleagues ... violence in the United States. The study, Trends in Fighting and Violence ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Dudnyk has announced ... emphasizes the agency’s conviction that the full potential of specialty and orphan brands can ... appreciated and aligned. , “The Unifying Effect is at the heart of a ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry , ... , an active lifestyle company that provides Human Performance Training and education to ... offers, first responders, military officers and others in service through the development and ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... in the category of International Trade, the UK’s most prestigious award for business ... which represents 95% of total revenues and has grown by a total of ...
(Date:4/21/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, wrote ... global crisis with solution to peace plan. Yisrayl says war has never brought peace and ... by the Creator Himself. , Yisrayl says war drums are beating all over the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  SARES•REGIS Group leased the first ... at Conejo Spectrum Business Park in ... Biotherapeutics, Inc. , a biopharmaceutical company developing meaningful ... that have been underserved by scientific innovation, with ... cancer, autoimmune and infectious disease. Before ...
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/18/2017)... 18, 2017 Research and Markets has ... States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" ... ... equipment revenues as well as growth in the number of ... value to market participants that design and manufacture molecular imaging ...
Breaking Medicine Technology: